Fig. 2From: Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocolAssessment of pCR during treatment. CR complete response, PR partial response, SD stable disease, PD progressive disease. *Protocol treatment is haltedBack to article page